| abstract |
FIELD: medicine. n SUBSTANCE: pharmaceutical compositions include divalent, namely calcium, magnesium or zinc salt, of pravastatin or fluvastatin and omega-3 fat, for prevention, reduction or treatment of increased cholesterol levels, atherosclerosis, hyperlipidemia, cardio-vascular disorders and diseases, coronary heart disease and/or cerebrovascular disease. n EFFECT: improved bioavailability of compositions, easily obtained and introduced. n 40 cl, 33 dwg, 2 tbl, 8 ex |